DANAHER ($DHR) posted quarterly earnings results on Tuesday, April 22nd. The company reported earnings of $1.88 per share, beating estimates of $1.66 by $0.22. The company also reported revenue of $5,741,000,000, beating estimates of $5,645,252,680 by $95,747,320.
You can see Quiver Quantitative's $DHR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DANAHER Insider Trading Activity
DANAHER insiders have traded $DHR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:
- DANIEL RASKAS (SVP - Corporate Development) has made 0 purchases and 2 sales selling 34,688 shares for an estimated $8,218,556.
- BRIAN W ELLIS (Senior Vice President - GC) sold 5,700 shares for an estimated $1,277,541
- ALAN G SPOON sold 550 shares for an estimated $113,553
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DANAHER Hedge Fund Activity
We have seen 850 institutional investors add shares of DANAHER stock to their portfolio, and 1,168 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,601,092 shares (-91.9%) from their portfolio in Q4 2024, for an estimated $826,630,668
- FMR LLC removed 3,097,352 shares (-13.1%) from their portfolio in Q4 2024, for an estimated $710,997,151
- D. E. SHAW & CO., INC. added 2,109,520 shares (+40977.5%) to their portfolio in Q4 2024, for an estimated $484,240,316
- WELLINGTON MANAGEMENT GROUP LLP removed 1,987,430 shares (-8.5%) from their portfolio in Q4 2024, for an estimated $456,214,556
- LEGAL & GENERAL GROUP PLC removed 1,636,980 shares (-28.1%) from their portfolio in Q4 2024, for an estimated $375,768,759
- TWO SIGMA ADVISERS, LP added 1,601,800 shares (+4248.8%) to their portfolio in Q4 2024, for an estimated $367,693,190
- CAPITAL WORLD INVESTORS added 1,566,658 shares (+32.7%) to their portfolio in Q4 2024, for an estimated $359,626,343
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DANAHER Government Contracts
We have seen $177,924,990 of award payments to $DHR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- OTA - PANDEMIC PREPAREDNESS AND RESPONSE: ESTABLISHING A PLATFORM FOR DIAGNOSIS AND SURVEILLANCE OF EMERGIN...: $31,926,876
- POLYMERASE CHAIN REACTION (PCR) DIAGNOSTIC TESTING FOR VISN 2 DOWNSTATE: $3,781,390
- MOLECULAR DIAGNOSTIC TESTS FOR SARS-COV-2: $3,223,145
- IN-VITRO REAGENTS: $3,088,148
- CEPHEID MOLECULAR TESTING: $2,992,273
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
DANAHER Congressional Stock Trading
Members of Congress have traded $DHR stock 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $DHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 02/26.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $50,000 on 02/25.
- SENATOR MARKWAYNE MULLIN sold up to $50,000 on 02/13.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 01/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DANAHER Analyst Ratings
Wall Street analysts have issued reports on $DHR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 04/07/2025
- Guggenheim issued a "Buy" rating on 12/19/2024
To track analyst ratings and price targets for DANAHER, check out Quiver Quantitative's $DHR forecast page.
DANAHER Price Targets
Multiple analysts have issued price targets for $DHR recently. We have seen 5 analysts offer price targets for $DHR in the last 6 months, with a median target of $260.0.
Here are some recent targets:
- Catherine Ramsey Schulte from Robert W. Baird set a target price of $231.0 on 04/16/2025
- An analyst from Stifel Nicolaus set a target price of $260.0 on 03/14/2025
- Matthew Sykes from Goldman Sachs set a target price of $250.0 on 01/15/2025
- Subbu Nambi from Guggenheim set a target price of $275.0 on 12/19/2024
- Doug Schenkel from Wolfe Research set a target price of $285.0 on 10/31/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
